BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32284737)

  • 21. Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation.
    Guest SK; Ribas R; Pancholi S; Nikitorowicz-Buniak J; Simigdala N; Dowsett M; Johnston SR; Martin LA
    PLoS One; 2016; 11(6):e0157397. PubMed ID: 27308830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reciprocal regulation of chromatin state and architecture by HOTAIRM1 contributes to temporal collinear HOXA gene activation.
    Wang XQ; Dostie J
    Nucleic Acids Res; 2017 Feb; 45(3):1091-1104. PubMed ID: 28180285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of HOXB cluster genes are epigenetically regulated in tamoxifen-resistant MCF7 breast cancer cells.
    Yang S; Lee JY; Hur H; Oh JH; Kim MH
    BMB Rep; 2018 Sep; 51(9):450-455. PubMed ID: 29804556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
    Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
    Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA H19 mediated the chemosensitivity of breast cancer cells via Wnt pathway and EMT process.
    Gao H; Hao G; Sun Y; Li L; Wang Y
    Onco Targets Ther; 2018; 11():8001-8012. PubMed ID: 30519041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.
    Choi HJ; Joo HS; Won HY; Min KW; Kim HY; Son T; Oh YH; Lee JY; Kong G
    J Natl Cancer Inst; 2018 Apr; 110(4):. PubMed ID: 29028222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer.
    Kim CY; Kim YC; Oh JH; Kim MH
    J Cancer; 2021; 12(15):4626-4637. PubMed ID: 34149926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells.
    Vaziri-Gohar A; Zheng Y; Houston KD
    Mol Cancer Res; 2017 Apr; 15(4):489-497. PubMed ID: 28096479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of ER-α36 expression sensitizes HER2 overexpressing breast cancer cells to tamoxifen.
    Yin L; Pan X; Zhang XT; Guo YM; Wang ZY; Gong Y; Wang M
    Am J Cancer Res; 2015; 5(2):530-44. PubMed ID: 25973295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway.
    Chen ZH; Wang WT; Huang W; Fang K; Sun YM; Liu SR; Luo XQ; Chen YQ
    Cell Death Differ; 2017 Feb; 24(2):212-224. PubMed ID: 27740626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combination of transcriptome and methylation analyses reveals the role of lncRNA
    Lai GE; Zhou J; Huang CL; Mai CJ; Lai YM; Lin ZQ; Peng T; Luo Y; Liu FE
    Gland Surg; 2022 May; 11(5):826-836. PubMed ID: 35694102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Suppression of long non-coding RNA CCAT2 improves tamoxifen-resistant breast cancer cells' response to tamoxifen].
    Cai Y; He J; Zhang D
    Mol Biol (Mosk); 2016; 50(5):821-827. PubMed ID: 27830684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HOXA1 Is an Antagonist of ERα in Breast Cancer.
    Belpaire M; Ewbank B; Taminiau A; Bridoux L; Deneyer N; Marchese D; Lima-Mendez G; Baurain JF; Geerts D; Rezsohazy R
    Front Oncol; 2021; 11():609521. PubMed ID: 34490074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From Micro to Long: Non-Coding RNAs in Tamoxifen Resistance of Breast Cancer Cells.
    Barazetti JF; Jucoski TS; Carvalho TM; Veiga RN; Kohler AF; Baig J; Al Bizri H; Gradia DF; Mader S; Carvalho de Oliveira J
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of DNMT3b contributes to HOTAIRM1 silencing via DNA hypermethylation in cells transformed by long-term exposure to hydroquinone and workers exposed to benzene.
    Zhang H; Yuan Q; Pan Z; Ling X; Tan Q; Wu M; Zheng D; Xie P; Xie D; Liu L
    Toxicol Lett; 2020 Apr; 322():12-19. PubMed ID: 31899212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA HOTAIRM1 Inhibits the Proliferation and Invasion of Lung Adenocarcinoma Cells via the miR-498/WWOX Axis.
    Chen TJ; Gao F; Yang T; Li H; Li Y; Ren H; Chen MW
    Cancer Manag Res; 2020; 12():4379-4390. PubMed ID: 32606933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic Features and the Prognostic Implications of Long Noncoding RNA
    Xiong F; Yin H; Zhang H; Zhu C; Zhang B; Chen S; Ling C; Chen X
    Genet Test Mol Biomarkers; 2020 Jan; 24(1):47-53. PubMed ID: 31880484
    [No Abstract]   [Full Text] [Related]  

  • 38. Downregulation of microRNA-1469 promotes the development of breast cancer via targeting HOXA1 and activating PTEN/PI3K/AKT and Wnt/β-catenin pathways.
    Zhang Y; Fang J; Zhao H; Yu Y; Cao X; Zhang B
    J Cell Biochem; 2019 Apr; 120(4):5097-5107. PubMed ID: 30320894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of LINC00894-002 Contributes to Tamoxifen Resistance by Enhancing the TGF-β Signaling Pathway.
    Zhang X; Wang M; Sun H; Zhu T; Wang X
    Biochemistry (Mosc); 2018 May; 83(5):603-611. PubMed ID: 29738694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer.
    Zhou Y; Yau C; Gray JW; Chew K; Dairkee SH; Moore DH; Eppenberger U; Eppenberger-Castori S; Benz CC
    BMC Cancer; 2007 Apr; 7():59. PubMed ID: 17407600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.